Pharmacometabolomics studies to identify key metabolic pathways and determine metabolomic biomarkers associated with compound exposure and metabolic response, supporting ADME and mechanistic insight in preclinical research.
Pharmacometabolomics studies to identify key metabolic pathways and determine metabolomic biomarkers associated with compound exposure and metabolic response, supporting ADME and mechanistic insight in preclinical research.